can tirzepatide make you feel like you have the flu side effects: What to know Understanding Tirzepatide Side Effects, Risks

Update on the management of upper gastrointestinal bleeding

IGF-1 LR3 in humans There are no published Phase 2 or Phase 3 human RCTs evaluating IGF-1 LR3 for body composition, fat loss, or muscle accretion in healthy or metabolically compromised adults

2023 review confirms benefits on anemia and muscle cramps

Oral aphthous: pathophysiology, clinical aspects and medical treatment

Anti-IGF-1 receptor (IGF-1R) monoclonal antibodies (mAbs) were developed for clinical use in treating advanced stage cancers 22,23,24 , including Ganitumab, which remains under investigation as a combination therapy in clinical trials targeting Rhabdomyosarcoma (NCT03041701) and Ewing Sarcoma (NCT02306161), for which it recently received orphan drug status